Surgery – Diagnostic testing
Reexamination Certificate
1998-03-31
2001-05-22
Hindenburg, Max (Department: 3736)
Surgery
Diagnostic testing
Reexamination Certificate
active
06234965
ABSTRACT:
BACKGROUND OF THE INVENTION
The present invention relates to techniques for improving biochemical-based therapy in a human. More particularly, the present invention relates to computer-implemented techniques for employing task-controlled behavioral assessment and behavioral training, such as stimulus/response exercises or games, to improve the efficacy of the biochemical-based therapy to reduce or eliminate the need thereof, or to reduce the undesirable side effects of the biochemical-based therapy in a human.
The use of biochemical-based therapy involving various biological and/or chemical compounds to address a physiological and/or mental condition in humans is known. Generally speaking, biochemical-based therapy involves repeatedly administering a preset dosage of a biological/chemical compound to a human (by injection, ingestion, transdermal techniques, and/or the like) over a period of time to improve the aforementioned physiological and/or mental condition. By stimulating the human in a pharmacological manner, it is often hoped that over time the physiological and/or mental condition to be addressed would improve to the point where the biochemical-based therapy is no longer needed.
To facilitate discussion, scale
100
of
FIG. 1
represents a scale of performance level relating to a particular physiological and/or mental condition (such as, for example, attention span) on which a desired condition
102
represents the level of performance acceptable and/or desirable in a human. On scale
100
, the levels of performance by a human A and a human B are shown. As depicted, the levels of performance of humans A and B fall short of desired condition
102
. To bring the levels of performance of humans A and B closer to desired condition
102
, the prior art biochemical-based therapy may involve administering preset dosages of a biological and/or chemical compound over a predefined period of time to human A and human B. By driving the improvement in a pharmacological manner, it is commonly hoped that over time the level of performance of humans A and B in this particular condition (e.g., attention span) may improve to the point where the dosages of biological and/or chemical compound may be reduced or terminated altogether.
It has been found, however, that when the improvement in human is driven solely by pharmacological effects of the administered biological/chemical compounds, humans tend to develop a tolerance condition, which over time may actually require an increase in the required dosage of the biological/chemical compounds administered.
Furthermore, for many administered biological/chemical compounds, there are side effects which must be tolerated and/or addressed with even more biochemical-based therapy (e.g., by administering yet other biological/chemical compounds to address the side effects). With reference to
FIG. 2A
, scale
200
represents the scale of performance pertaining to a particular condition of the human, which condition may be impacted as an undesirable side effect of the biochemical-based therapy administered to address the first ailment or deficit (e.g., such as the attention deficit condition of the example of FIG.
1
). Scale
200
may represent, for example, the level of sleepiness or hand shaking in the human subject.
In
FIG. 2A
, the intrinsic levels of sleepiness, i.e., the levels of sleepiness in the absence of the biochemical-based therapy, of humans A and B are shown. In
FIG. 2B
, the administration of the biochemical-based therapy to address the related attention deficit condition has undesirably increased the levels of sleepiness in humans A and B. As mentioned earlier this undesirable side effect just, in the prior art, either be tolerated (such as avoiding driving) or addressed with yet more biochemical-based therapy (such as ingesting caffeine).
Furthermore, it is recognized that even if immediate side effects are not observed in connection with a given biochemical-based therapy regime, there are lingering concerns regarding the long term effects associated with the administration of biological/chemical compounds which may not be naturally produced by human. Accordingly, recent trends have shown an increased reluctance on the part of people to continue a biochemical-based therapy program for an extended period of time and/or to take increasing dosages of biological/chemical compounds (due to, e.g., the aforementioned tolerance problem) to address a particular physiological and/or mental condition.
In view of the foregoing, there are desired improved techniques for improving the efficacy of the biological/chemical compounds employed in biochemical-based therapy and/or for reducing the undesirable side effects thereof without employing additional biochemical-based therapy.
SUMMARY OF THE INVENTION
The invention relates, in one embodiment, to a computer-implemented method for improving biochemical-based therapy, or other forms of therapy such as surgery or radiation, in a human. By way of example, biomedical-based therapy may include repeatedly administering a biochemical portion (e.g., a biological and/or a chemical compound) to the human. Using the biochemical-based therapy for discussion, the computer-implemented method may include administering, using a computer, a first stimulus/response exercise to the human to measure at least one of an efficacy of the biochemical portion on the human and an undesirable side effect of the biochemical portion on the human. If the administering the first stimulus/response exercise measures the efficacy of the biochemical portion on the human, the method further includes improving the efficacy of the biochemical portion on the human by identifying a second stimulus/response exercise that at least maintains the efficacy of the biochemical portion on the human, and administering, using the computer, the second stimulus/response exercise to the human.
If the administering the first stimulus/response exercise measures the undesirable effect of the biochemical portion on the human, reducing the undesirable effect of the biochemical portion on the human by identifying a third stimulus/response exercise that reduces the undesirable side effect of the biochemical portion on the human, and administering, using the computer, the third stimulus/response exercise to the human. It should be appreciated that the above discussion applies to other types of therapy (e.g., radiation) and that the stimulus/responses are not limited to behavioral responses (e.g., the stimulus and responses may also include responses that are physiological in nature).
REFERENCES:
patent: 4839822 (1989-06-01), Dornord et al.
patent: 4996988 (1991-03-01), Ohhara et al.
patent: 5678571 (1997-10-01), Brown
patent: 5722418 (1998-03-01), Bro
patent: 5725472 (1998-03-01), Weathers
patent: 5776055 (1998-07-01), Haye
patent: 5910107 (1999-06-01), Iliff
patent: 5913310 (1999-06-01), Brown
patent: WO 93/02622 (1993-02-01), None
patent: WO 94/04072 (1994-03-01), None
patent: WO 94/06088 (1994-03-01), None
patent: WO 95/29447 (1995-11-01), None
patent: WO 97/06730 (1997-02-01), None
patent: WO 97/34526 (1997-09-01), None
Roger Jelliffe, et al., Adaptive control of drug dosage regimens: basic foundations, relevant issues, and clinical examples, International Journal of Bio-Medical Computing 36, (pp. 1-23), © 1994.
Schneider et al. Self-Regulation of Slow Cortical Potentials in Psychiatric Patients: Schizophrenia, © Dec. 1992, Biofeedback and Self-Regulation, vol. 17, No. 4, pp. 277-292.
Tretter F., Perspectives of Computer-Aided Therapy and Rehabilitation in Psychiatry, Jul. 1996, pp. 475-486.
Hermanutz M. and Gestrich J., Computer-assisted Attention Training in Schizophrenics, 1991, European Archives of Psychiatry and Clinical Neuroscience, vol. 240, pp. 282-287.
Nagarajan et al., “Practice-Related Improvements in Somatosensory Interval Discrimination Are Temporally Specific But Generalize Across Skin Location, Hemisphere, and Modality,” Feb. 15, 1998, The Journal of Neuroscience, pp. 1559-1570.
Miller et al., “Improvements in Language Abilities w
Merzenich Michael M.
Miller Steven L.
Peterson Bret E.
Beyer Weaver & Thomas LLP
Hindenburg Max
Scientific Learning Corporation
LandOfFree
Methods and apparatus for improving biochemical based... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and apparatus for improving biochemical based..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and apparatus for improving biochemical based... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2437653